- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1926
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Clinical Pharmacokinetic Studies of Enzalutamide ; volume:54 ; number:10 ; day:28 ; month:4 ; year:2015 ; pages:1043-1055 ; date:10.2015
Clinical pharmacokinetics ; 54, Heft 10 (28.4.2015), 1043-1055, 10.2015
- Urheber
-
Gibbons, Jacqueline A.
Ouatas, Taoufik
Krauwinkel, Walter
Ohtsu, Yoshiaki
Walt, Jan-Stefan van der
Beddo, Vanessa
Vries, Michiel de
Mordenti, Joyce
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40262-015-0271-5
- URN
-
urn:nbn:de:101:1-2019102815200610178110
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gibbons, Jacqueline A.
- Ouatas, Taoufik
- Krauwinkel, Walter
- Ohtsu, Yoshiaki
- Walt, Jan-Stefan van der
- Beddo, Vanessa
- Vries, Michiel de
- Mordenti, Joyce
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pharmacokinetic Drug Interaction Studies with Enzalutamide
Physiologically-based pharmacokinetic modeling to predict drug-drug interaction of enzalutamide with combined P-gp and CYP3A substrates
Comment on: “Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer”
Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Towards optimal design of anti-malarial pharmacokinetic studies
Changing the Timing of Enzalutamide Intake from Morning to before Sleep at Night Overcame Enzalutamide-Induced Dysgeusia
Gas Chromatography–Mass Spectrometry Detection of Thymoquinone in Oil and Serum for Clinical Pharmacokinetic Studies
Lack of Clinical Pharmacokinetic Studies to Optimize the Treatment of Neglected Tropical Diseases: A Systematic Review
Molecular Mechanisms of Enzalutamide Resistance in Prostate Cancer
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
Pharmacokinetic Drug Interaction Studies with Enzalutamide
Physiologically-based pharmacokinetic modeling to predict drug-drug interaction of enzalutamide with combined P-gp and CYP3A substrates
Comment on: “Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer”
Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Towards optimal design of anti-malarial pharmacokinetic studies
Changing the Timing of Enzalutamide Intake from Morning to before Sleep at Night Overcame Enzalutamide-Induced Dysgeusia
Gas Chromatography–Mass Spectrometry Detection of Thymoquinone in Oil and Serum for Clinical Pharmacokinetic Studies
Lack of Clinical Pharmacokinetic Studies to Optimize the Treatment of Neglected Tropical Diseases: A Systematic Review
Molecular Mechanisms of Enzalutamide Resistance in Prostate Cancer
Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic Review
Pharmacokinetic Drug Interaction Studies with Enzalutamide
Physiologically-based pharmacokinetic modeling to predict drug-drug interaction of enzalutamide with combined P-gp and CYP3A substrates
Comment on: “Enzalutamide: A Step Towards Pharmacokinetic-Based Dosing in Men with Metastatic Castration-Resistant Prostate Cancer”
Pharmacokinetic Aspects of the Two Novel Oral Drugs Used for Metastatic Castration-Resistant Prostate Cancer: Abiraterone Acetate and Enzalutamide
Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat
Towards optimal design of anti-malarial pharmacokinetic studies
Changing the Timing of Enzalutamide Intake from Morning to before Sleep at Night Overcame Enzalutamide-Induced Dysgeusia
Gas Chromatography–Mass Spectrometry Detection of Thymoquinone in Oil and Serum for Clinical Pharmacokinetic Studies
Lack of Clinical Pharmacokinetic Studies to Optimize the Treatment of Neglected Tropical Diseases: A Systematic Review
Molecular Mechanisms of Enzalutamide Resistance in Prostate Cancer